Therefore, nicorandil-induced coronary vasodilatation, upregulation of VEGF expression, improvement of SERCA2 gene expression, and inhibition of ventricular interstitial fibrosis might prevent the progression of heart failure. This evidence concerns the gene ATP2A2 and heart failure.